Crenigacestat (LY3039478) Crenigacestat inhibitor Microenvironment Remodeling in Cholangiocarcinoma

Compstatin targeted C3 complement inhibition suppresses malaria parasite phagocytosis

MK-571 (L-660711) LTR inhibitor targeted MRP2 inhibition restores epirubicin sensitivity in hepatocellular carcinoma

Monastrol Inhibition of Kinesin-5 (Eg5) Accelerates Axonal Regeneration and Peripheral Remyelination

Tat-beclin 1 Tatbeclin 1 from Selleck Target BECN1 for Ischemic Stroke Neuroprotection

PKR-IN-C16 PKR inhibitor modulating C16 transition metal boride electronic structure and magnetic anisotropy

Firsocostat targeted inhibition of acetyl-CoA carboxylase restores Leydig cell steroidogenesis in metabolic dysfunction

Vorapaxar and PAR-1 Inhibition for Long-Term Prevention of Atherothrombotic Events

Tiplaxtinin PAI-1 inhibitor Tiplaxtinin (PAI-039) regulates CHRNA1 expression in cholinergic sweat gland secretion

Dooku1 Mechanosensitive Cha Antagonism Accelerates Trigeminal Axonal Regeneration Post-Axotomy

NNMTi NNMT inhibitor Disruption of Methylation Dynamics Restores Epigenetic Control in Solid Tumors

BMS-303141 Inhibits ATP Citrate Lyase to Suppress Hepatic Alanine-Driven Gluconeogenesis

BMS-309403 from Selleck inhibits FABP4 to attenuate steatotic liver ischemia-reperfusion injury

WRW4 FPR antagonist attenuates formyl peptide receptor 2 signaling in stem cells